Nine Months of Fluoxetine Aids in the Reduction of Posttraumatic Stress Symptoms following a Traumatic Musculoskeletal Injury: A Randomized Controlled Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 42441660.
- Also identified by DOI 10.1097/BOT.0000000000003243.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine whether Fluoxetine, prescribed by orthopaedic providers during the immediate post-traumatic period, can lessen post-traumatic stress symptoms in survivors of traumatic musculoskeletal injuries. Design: Non-Blinded Prospective Randomized Clinical Trial. Single Academic Level 1 Trauma Center. From July 2021 to December 2023, orthopaedic surgical patients admitted for a high-energy musculoskeletal trauma (injuries not resulting from a ground level fall or less) were randomized to receive 9 months of Fluoxetine (Prozac®) or Placebo (Calcium). Outcomes were collected five times over the course of one year (2 weeks, 6 weeks, 3 months, 6 months, and 12 months). Patient-reported outcome measures evaluated depression (Beck Depression Inventory, BDI-II), anxiety (Beck Anxiety Inventory, BAI), Post-Traumatic Stress Disorder (PTSD) (PTSD Scale-Self report for DSM-5, PSS-SR), sleep (Pittsburgh Sleep Quality Index, PSQI), pain ( Pain, Enjoyment, General Activity Scale, PEG), and social enjoyment (PROMIS - Ability to participate Social, and PROMIS - Social Isolation ). The two groups (Fluoxetine = 33, Calcium = 35) were similar in terms of age (Fluoxetine = 43.5 years (SD 15.8, range = 18-73), Calcium = 40.3 years (SD 17.7, range18-70 )) and sex (Fluoxetine =14 females, Calcium = 15 females). Subjects randomized to fluoxetine showed an improvement in PTSD symptoms over time (estimate = -0.2, 95%: -0.4, -0.0; with negative numbers indicating lessening symptoms), while those randomized to calcium exhibited little to no change (estimate = 0.1, 95%: -0.1, 0.3). Additionally, subjects in the fluoxetine group (estimate = -0.1, 95% CI: -0.1, -0.0, negative numbers indicating a decrease in pain) showed a significant improvement in pain over time, whereas the calcium group showed no significant change (estimate = -0.0, 95% CI: -0.0, 0.0). There were no significant changes over time in BDI scores (F1,159 = 0.0, p = 0.9), BAI scores (F1,169.4 = 0.0, p = 0.9), or PROMIS measure Social Isolation (F1,142.9 = 0.5, p = 0.5). Nine months of fluoxetine following a traumatic musculoskeletal injury decreased the severity of post-traumatic stress symptoms and pain throughout the recovery period. Level II.